[Pregnancy following organ transplantation]. 1990

H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
Urologische Klinik, Universitäts-Krankenhaus Hamburg-Eppendorf.

In 17 of 74 patients, in the 20-40 years of age group, who had undergone an organ transplantation (kidney or liver), the course and outcome of pregnancy were evaluated. In three cases, the pregnancies ended in premature miscarriage and in five cases they were terminated for medical reasons. Nine infants were born alive between the 32nd to the 40th week of gestation, six of them spontaneously, three of them by abdominal Caesarean section. One of these infants born in the 32nd week of gestation with a birth weight of 800 grams died on the second day after birth. One infant born in the 33rd week of gestation showed incidence of a persistent ductus arteriosis Botalli. Four of the nine newborns suffered from intrauterine dystrophy. The birth weight of four further infants corresponded to the 10th to 25th percentile. Neither the incidence of a maternal varicella zoster infection in the early stages of pregnancy nor the reactivation of a herpes simplex (HSV) and cytomegalia virus infection during the pregnancy resulted in any perceptible damage to the infant or transplant. During pregnancy, three of the mothers were treated with immunosuppressants, either with a combination of azathioprine and prednisone (conventional) or cyclosporine (CSA) and prednisone, or with a combination of all three drugs (triple therapy). As opposed to the newborn of those mothers, who had been treated conventionally, the newborn of those treated with CSA showed post partum a tendency towards hypocalcaemia. Two of the mothers gave birth to their infants outside the Federal Republic of Germany.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D005260 Female Females
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections

Related Publications

H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
January 1991, Zentralblatt fur Gynakologie,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
November 2005, Nihon rinsho. Japanese journal of clinical medicine,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
June 1995, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
September 1996, Harefuah,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
March 2009, Neuro endocrinology letters,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
November 1996, Presse medicale (Paris, France : 1983),
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
January 1994, Nordisk medicin,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
February 2000, Der Anaesthesist,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
June 2009, Ophthalmology,
H Kraemer-Hansen, and E Goepel, and H U Ulmer, and M Bitzan, and C Press, and A Kopp, and D Henne-Bruns, and B Kremer
August 1991, Pneumologie (Stuttgart, Germany),
Copied contents to your clipboard!